These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2284184)

  • 1. [Benzonal in the complex treatment of hemolytic disease of newborn].
    Daminov TA; Akhmedova DI
    Pediatriia; 1990; (10):68-73. PubMed ID: 2284184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of a new Soviet drug Benzonal, inductor of microsomal enzymes of the liver, in the complex treatment of hemolytic disease of newborn].
    Daminov TA; Akhmedova DI
    Vestn Akad Med Nauk SSSR; 1990; (8):18-21. PubMed ID: 2275270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of phototherapy in ABO hemolytic disease of the newborn.
    Bajpai PC; Misra PK; Das VK; Tripathi TK; Kapoor CL
    Indian J Med Res; 1973 Nov; 61(11):1658-65. PubMed ID: 4799677
    [No Abstract]   [Full Text] [Related]  

  • 4. 50 years ago in the Journal of Pediatrics: Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn.
    Watchko JF
    J Pediatr; 2014 Jul; 165(1):64. PubMed ID: 24973159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phototherapy and treatment with phenobarbital in hemolytic disease of newborn due to Rh-incompatibility].
    Menzel K; Schambach K; Töpke B
    Acta Paediatr Acad Sci Hung; 1974; 15(3-4):333-9. PubMed ID: 4219868
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 7. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fractional determination of bilirubin in hemolytic disease of newborn infants].
    Iuzhakova KF
    Vopr Okhr Materin Det; 1965 Oct; 10(10):28-33. PubMed ID: 5896274
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The presence of direct bilirubin in the serum in hemolytic disease of the newborn].
    SACREZ R; JUIF JG; GEX M; WILLARD D; BEAUVAIS P
    Ann Pediatr (Paris); 1962 May; 9():317-23. PubMed ID: 14495884
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of the quantitative determination of direct and indirect bilirubin in hemolytic disease of the newborn.
    JIRSOVA V; JIRSA M; JANOVSKY M
    Acta Paediatr (Stockh); 1958 Mar; 47(2):179-86. PubMed ID: 13508237
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications for exchange transfusion independent of the bilirubin levels in the newborn with hemolytic diseases].
    de Almeida JM
    Rev Port Pediatr Pueric; 1969; 32(3):77-86. PubMed ID: 5817830
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic significance of the determination of bilirubin fractions in the hemolytic disease of newborns].
    Hodr R; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(1):21-7. PubMed ID: 5239111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neonatal jaundice in the premature infant. Bilirubinemic level and indications for exchange transfusion].
    Cadorini S
    Minerva Pediatr; 1968 Sep; 20(38):1945-52. PubMed ID: 5754458
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathochemical principles of therapy in hemolytic disease of the newborn].
    Kalinicheva VI; Filippov ES; Panchenko AI; Bashnina EB
    Pediatriia; 1984 Nov; (11):53-8. PubMed ID: 6441922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of hyperbilirubinemia in the newborn using bilirubin curves from infants with hemolytic diseases].
    Arroyo Bornstein A; Manuel Septién J; Crespo Cortina M; Alvarez de los Cobos J; Escalante Vázquez E
    Ginecol Obstet Mex; 1969 May; 24(151):479-87. PubMed ID: 5388424
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of hyperbilirubinemia as a guide for the use of exchange transfusions in hemolytic disease in the newborn infant.
    PIERCE M; RIGOR E
    J Am Med Womens Assoc; 1957 Aug; 12(8):247-53. PubMed ID: 13462877
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of MN subgroup incompatibility with intravenous immunoglobulin in a newborn.
    Gursoy T; Tekinalp G; Yigit S; Korkmaz A; Onderoglu L
    Pediatr Int; 2007 Feb; 49(1):97-9. PubMed ID: 17250514
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple test for evaluating bilirubin binding by the serum of infants with hemolytic disease and kernicterus.
    Blondheim SH; Kapitulnik J; Kaufmann NA
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):612-3. PubMed ID: 5168204
    [No Abstract]   [Full Text] [Related]  

  • 20. Male newborn with anti-Kg antibody-induced hemolytic disease of the newborn.
    Kubo S; Takahashi J; Yoshizawa H; Ohgitani A; Ezaki T; Tsubaki K; Tani Y; Minowa H
    Pediatr Int; 2009 Aug; 51(4):582-4. PubMed ID: 19674370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.